CAMP4 Therapeutics Statistics
NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.79-0.21 (-5.25%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CAMP4 Therapeutics by the numbers
CAMP4 Therapeutics has a market capitalization of $237.8 million based on 62.75M shares outstanding. With trailing EPS of $-2.11, CAMP4 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.8% below its 50-day average and 9.9% below its 200-day average.
Average daily trading volume is 238.88K shares, or about $905,340 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CAMP valuation vs. peer median
| Metric | CAMP | Peer median | Difference |
|---|---|---|---|
| Market cap | $237.84M | $232.20M | +2% |
| Avg. volume | 238.88K | 423.72K | -44% |
Peer median across 8 companies: LFCR, TTRX, QTTB, ENTA, IMRX, RCKT, KROS, PRLD.
Valuation
- Market cap
- $237.84M
- Price / sales (latest FY)
- 67.99
- EPS (TTM)
- $-2.11
- Shares outstanding
- 62.75M
Price and trading
- Previous close
- 4.00
- Open
- 3.95
- Day range
- 3.78 – 4.00
- 52-week range
- 2.90 – 7.75
- 52-week change
- +30.69%
- Beta
- —
- Volume
- 88.48K
- Average volume
- 238.88K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 237.84M
- Forward Pe
- -4.49
- Eps
- -2.11
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.75
- Week52 Low
- 2.90
- Avg Volume
- 238.88K
- Shares Outstanding
- 62.75M
- Ma50
- 3.82
- Ma200
- 4.21
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -51.10%
- Pct From52w Low
- 30.69%